IN2014DN06966A - - Google Patents

Info

Publication number
IN2014DN06966A
IN2014DN06966A IN6966DEN2014A IN2014DN06966A IN 2014DN06966 A IN2014DN06966 A IN 2014DN06966A IN 6966DEN2014 A IN6966DEN2014 A IN 6966DEN2014A IN 2014DN06966 A IN2014DN06966 A IN 2014DN06966A
Authority
IN
India
Prior art keywords
relates
pregabalin
preparation
pharmaceutically acceptable
same
Prior art date
Application number
Other languages
English (en)
Inventor
Varinder Kumar
Shavej Ahmad
Romi Barat Singh
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48014113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN06966(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN6966DEN2014 priority Critical patent/IN2014DN06966A/en
Publication of IN2014DN06966A publication Critical patent/IN2014DN06966A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN6966DEN2014 2012-01-30 2013-01-29 IN2014DN06966A (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN6966DEN2014 IN2014DN06966A (da) 2012-01-30 2013-01-29

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN250DE2012 2012-01-30
IN252DE2012 2012-01-30
PCT/IB2013/050764 WO2013114283A1 (en) 2012-01-30 2013-01-29 Gastroretentive tablets
IN6966DEN2014 IN2014DN06966A (da) 2012-01-30 2013-01-29

Publications (1)

Publication Number Publication Date
IN2014DN06966A true IN2014DN06966A (da) 2015-04-10

Family

ID=48014113

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6966DEN2014 IN2014DN06966A (da) 2012-01-30 2013-01-29

Country Status (7)

Country Link
US (1) US9393205B2 (da)
EP (1) EP2809304A1 (da)
AU (1) AU2013213769A1 (da)
CA (1) CA2863376A1 (da)
IN (1) IN2014DN06966A (da)
WO (1) WO2013114283A1 (da)
ZA (1) ZA201405581B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013114281A1 (en) * 2012-01-30 2013-08-08 Ranbaxy Laboratories Limited Pregabalin gr tablets
US20160338949A1 (en) * 2014-01-28 2016-11-24 Sun Pharmaceutical Industries Limited Stabilized gastroretentive tablets of pregabalin
WO2015174684A1 (ko) * 2014-05-14 2015-11-19 동아에스티 주식회사 방출제어된 위체류 서방성 제제
EP3498260A1 (en) * 2017-12-12 2019-06-19 Pro.Med.CS Praha A.S. Oral gastroretentive sustained-release pharmaceutical formulation
KR20190111784A (ko) 2018-03-22 2019-10-02 닛토덴코 가부시키가이샤 프레가발린 함유 조성물의 제조 방법 및 프레가발린 함유 조성물
WO2019238068A1 (zh) 2018-06-13 2019-12-19 北京泰德制药股份有限公司 一种普瑞巴林缓释组合物及其制备方法
CN111053749B (zh) * 2018-10-16 2022-07-15 北京泰德制药股份有限公司 一种普瑞巴林缓释组合物及其制备方法
CN110974798A (zh) * 2019-12-19 2020-04-10 江苏优仿医药科技有限公司 药物组合物、缓释片剂及其制备方法
CN114796142A (zh) * 2022-04-08 2022-07-29 黄山学院 萘普生胃漂浮片及其制备方法
GB2624861A (en) * 2022-11-28 2024-06-05 Orbit Pharma Ltd Sustained release pharmaceutical compositions comprising pregabalin or pharmaceutically acceptable salts thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US8454993B2 (en) 2007-11-23 2013-06-04 Lupin Limited Controlled release pharmaceutical compositions of pregabalin
WO2010143052A1 (en) 2009-06-12 2010-12-16 Micro Labs Limited Novel pharmaceutical compositions containing pregabalin
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs

Also Published As

Publication number Publication date
CA2863376A1 (en) 2013-08-08
AU2013213769A1 (en) 2014-08-21
ZA201405581B (en) 2015-06-24
EP2809304A1 (en) 2014-12-10
US9393205B2 (en) 2016-07-19
WO2013114283A1 (en) 2013-08-08
US20150025146A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
IN2014DN06966A (da)
EP4249055A3 (en) Tofacitinib oral sustained release dosage forms
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
MX364229B (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
MX356210B (es) Formulaciones de polimero acrilico.
PH12016501841A1 (en) Immunosuppressant formulation
IN2015DN03984A (da)
PH12014502856A1 (en) Solid pharmaceutical preparation containing levothyroxine
IN2014DN06965A (da)
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
IN2013MU01985A (da)
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
IN2013MU01111A (da)
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
PH12014502325A1 (en) Sustained release tablet containing levodropropizine and method for preparing same
IN2012DE00826A (da)
IN2013MU03370A (da)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2013CH04314A (da)
MX2014010038A (es) Tabletas dispersables con sabor enmascarado.
WO2014013090A3 (en) Formulation comprising amorphous fingolimod
IN2013MU02631A (da)
IN2013MU03426A (da)
IN2014MU00781A (da)